Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials

Young women with breast cancer (BC) have a worse survival partly due to more aggressive tumor characteristics; however, their response to chemotherapy seems better. We investigated to what extent the prognostic factor pathological complete remission (pCR) after neoadjuvant chemotherapy is applicable...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Loibl, Sibylle (VerfasserIn) , Jackisch, Christian (VerfasserIn) , Lederer, Bianca (VerfasserIn)
Weitere Verfasser: Untch, Michael (BerichterstatterIn) , Paepke, Stefan (BerichterstatterIn) , Kümmel, Sherko (BerichterstatterIn) , Schneeweiss, Andreas (BerichterstatterIn) , Huober, Jens (BerichterstatterIn) , Hilfrich, Jörn (BerichterstatterIn) , Hanusch, Claus Alexander (BerichterstatterIn) , Gerber, Bernd (BerichterstatterIn) , Eidtmann, Holger (BerichterstatterIn) , Denkert, Carsten (BerichterstatterIn) , Costa, Serban Dan (BerichterstatterIn) , Blohmer, Jens-Uwe (BerichterstatterIn) , Nekljudova, Valentina (BerichterstatterIn) , Mehta, Keyur (BerichterstatterIn) , Minckwitz, Gunter von (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 25 June 2015
In: Breast cancer research and treatment
Year: 2015, Jahrgang: 152, Heft: 2, Pages: 377-387
ISSN:1573-7217
DOI:10.1007/s10549-015-3479-z
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s10549-015-3479-z
Verlag, Volltext: https://link.springer.com/article/10.1007/s10549-015-3479-z
Verlag, Abstract, Volltext: http://link.springer.com/article/10.1007/s10549-015-3479-z
Volltext
Verfasserangaben:$hSibylle Loibl, Christian Jackisch, Bianca Lederer, Michael Untch, Stefan Paepke, Sherko Kümmel, Andreas Schneeweiss, Jens Huober, Jörn Hilfrich, Claus Hanusch, Bernd Gerber, Holger Eidtmann, Carsten Denkert, Serban Dan Costa, Jens-Uwe Blohmer, Valentina Nekljudova, Keyur Mehta, Gunter von Minckwitz

MARC

LEADER 00000caa a2200000 c 4500
001 840614993
003 DE-627
005 20250223010351.0
007 cr uuu---uuuuu
008 151123s2015 xx |||||o 00| ||eng c
024 7 |a 10.1007/s10549-015-3479-z  |2 doi 
035 |a (DE-627)840614993 
035 |a (DE-576)9840614991 
035 |a (DE-599)GBV840614993 
035 |a (OCoLC)1340145219 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Loibl, Sibylle  |0 (DE-588)12433024X  |0 (DE-627)085790508  |0 (DE-576)294122753  |4 aut 
245 1 0 |a Outcome after neoadjuvant chemotherapy in young breast cancer patients  |b a pooled analysis of individual patient data from eight prospectively randomized controlled trials  |c $hSibylle Loibl, Christian Jackisch, Bianca Lederer, Michael Untch, Stefan Paepke, Sherko Kümmel, Andreas Schneeweiss, Jens Huober, Jörn Hilfrich, Claus Hanusch, Bernd Gerber, Holger Eidtmann, Carsten Denkert, Serban Dan Costa, Jens-Uwe Blohmer, Valentina Nekljudova, Keyur Mehta, Gunter von Minckwitz 
264 1 |c 25 June 2015 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Young women with breast cancer (BC) have a worse survival partly due to more aggressive tumor characteristics; however, their response to chemotherapy seems better. We investigated to what extent the prognostic factor pathological complete remission (pCR) after neoadjuvant chemotherapy is applicable to young women. 8949 patients with primary BC and follow-up from eight German neoadjuvant trials were included. A subgroup of 1453 patients <40 years was compared with women aged 40-49 and ≥50 years regarding pCR (ypT0 ypN0), as well as disease free survival (DFS), local recurrence free survival (LRFS), distant disease free survival (DDFS), and overall survival (OS) overall, according to pCR status and subtypes defined by hormone-receptor (HR) status and HER2. pCR was strongly associated with age without a clear age cut-off. The pCR rate was significantly higher in the young compared with other age groups (20.9 vs. 17.7 vs. 13.7 %; p < 0.001). This difference was confined to triple-negative breast cancer (TNBC) and HR +/HER2−. DFS, DDFS, LRFS, and OS were significantly worse for young women. Age was independently prognostic for survival in HR +/HER2−, with women <40 years without pCR having a worse DFS compared to their counterparts with pCR. Young women are more likely to achieve pCR after neoadjuvant chemotherapy, especially in HR +/HER2− and TNBC. Age is not an important prognostic factor in TNBC and HR−/HER2 + but is in HR +/HER2−. Young women with a luminal-like BC seem to benefit more from neoadjuvant chemotherapy than older women, which needs to be taken into account. 
700 1 |a Jackisch, Christian  |d 1960-  |0 (DE-588)1024193160  |0 (DE-627)71932730X  |0 (DE-576)368124908  |4 aut 
700 1 |a Lederer, Bianca  |4 aut 
700 1 |a Untch, Michael  |0 (DE-588)134268083  |0 (DE-627)566077914  |0 (DE-576)300413572  |4 oth 
700 1 |a Paepke, Stefan  |d 1964-  |0 (DE-588)17293639X  |0 (DE-627)697863484  |0 (DE-576)133790584  |4 oth 
700 1 |a Kümmel, Sherko  |d 1971-  |0 (DE-588)122704142  |0 (DE-627)082103372  |0 (DE-576)293388016  |4 oth 
700 1 |a Schneeweiss, Andreas  |d 1961-  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 oth 
700 1 |a Huober, Jens  |0 (DE-588)1059154676  |0 (DE-627)798048239  |0 (DE-576)415183898  |4 oth 
700 1 |8 1\p  |a Hilfrich, Jörn  |d 1941-  |0 (DE-588)1271308592  |0 (DE-627)1820077217  |4 oth 
700 1 |a Hanusch, Claus Alexander  |d 1972-  |0 (DE-588)130827525  |0 (DE-627)506018563  |0 (DE-576)298362279  |4 oth 
700 1 |a Gerber, Bernd  |d 1957-  |0 (DE-588)136713238  |0 (DE-627)585337608  |0 (DE-576)301234620  |4 oth 
700 1 |a Eidtmann, Holger  |d 1954-  |0 (DE-588)172619130  |0 (DE-627)673654575  |0 (DE-576)133478335  |4 oth 
700 1 |a Denkert, Carsten  |d 1969-  |0 (DE-588)118129929  |0 (DE-627)079261124  |0 (DE-576)291730604  |4 oth 
700 1 |a Costa, Serban Dan  |4 oth 
700 1 |a Blohmer, Jens-Uwe  |d 1962-  |0 (DE-588)122376641  |0 (DE-627)081907958  |0 (DE-576)293244227  |4 oth 
700 1 |a Nekljudova, Valentina  |4 oth 
700 1 |a Mehta, Keyur  |4 oth 
700 1 |a Minckwitz, Gunter von  |d 1964-  |0 (DE-588)172260035  |0 (DE-627)673296962  |0 (DE-576)133128202  |4 oth 
773 0 8 |i In  |t Breast cancer research and treatment  |d Dordrecht [u.a.] : Springer Science + Business Media B.V., 1981  |g 152(2015), 2, Seite 377-387  |h Online-Ressource  |w (DE-627)320433722  |w (DE-600)2004077-5  |w (DE-576)104194162  |x 1573-7217  |7 nnas  |a Outcome after neoadjuvant chemotherapy in young breast cancer patients a pooled analysis of individual patient data from eight prospectively randomized controlled trials 
773 1 8 |g volume:152  |g year:2015  |g number:2  |g pages:377-387  |g extent:11  |a Outcome after neoadjuvant chemotherapy in young breast cancer patients a pooled analysis of individual patient data from eight prospectively randomized controlled trials 
776 0 8 |i Erscheint auch als  |n Druck-Ausgabe  |t Outcome after neoadjuvant chemotherapy in young breast cancer patients  |d 2015  |w (DE-627)83263168X  |w (DE-576)9832631688 
856 4 0 |u http://dx.doi.org/10.1007/s10549-015-3479-z  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s10549-015-3479-z  |x Verlag  |3 Volltext 
856 4 0 |u http://link.springer.com/article/10.1007/s10549-015-3479-z  |x Verlag  |y Abstract  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20200824 
993 |a Article 
994 |a 2015 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |e 910000PS109972554  |e 910400PS109972554  |k 0/910000/  |k 1/910000/910400/  |p 7 
999 |a KXP-PPN840614993  |e 3742409336 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["$hSibylle Loibl, Christian Jackisch, Bianca Lederer, Michael Untch, Stefan Paepke, Sherko Kümmel, Andreas Schneeweiss, Jens Huober, Jörn Hilfrich, Claus Hanusch, Bernd Gerber, Holger Eidtmann, Carsten Denkert, Serban Dan Costa, Jens-Uwe Blohmer, Valentina Nekljudova, Keyur Mehta, Gunter von Minckwitz"]},"language":["eng"],"person":[{"family":"Loibl","role":"aut","display":"Loibl, Sibylle","given":"Sibylle"},{"given":"Christian","display":"Jackisch, Christian","role":"aut","family":"Jackisch"},{"display":"Lederer, Bianca","given":"Bianca","role":"aut","family":"Lederer"},{"display":"Untch, Michael","given":"Michael","role":"oth","family":"Untch"},{"display":"Paepke, Stefan","given":"Stefan","role":"oth","family":"Paepke"},{"display":"Kümmel, Sherko","given":"Sherko","family":"Kümmel","role":"oth"},{"family":"Schneeweiss","role":"oth","given":"Andreas","display":"Schneeweiss, Andreas"},{"given":"Jens","display":"Huober, Jens","role":"oth","family":"Huober"},{"family":"Hilfrich","role":"oth","display":"Hilfrich, Jörn","given":"Jörn"},{"given":"Claus Alexander","display":"Hanusch, Claus Alexander","family":"Hanusch","role":"oth"},{"family":"Gerber","role":"oth","display":"Gerber, Bernd","given":"Bernd"},{"display":"Eidtmann, Holger","given":"Holger","role":"oth","family":"Eidtmann"},{"family":"Denkert","role":"oth","display":"Denkert, Carsten","given":"Carsten"},{"family":"Costa","role":"oth","display":"Costa, Serban Dan","given":"Serban Dan"},{"role":"oth","family":"Blohmer","display":"Blohmer, Jens-Uwe","given":"Jens-Uwe"},{"family":"Nekljudova","role":"oth","display":"Nekljudova, Valentina","given":"Valentina"},{"display":"Mehta, Keyur","given":"Keyur","role":"oth","family":"Mehta"},{"family":"Minckwitz","role":"oth","given":"Gunter von","display":"Minckwitz, Gunter von"}],"recId":"840614993","id":{"doi":["10.1007/s10549-015-3479-z"],"eki":["840614993"]},"physDesc":[{"extent":"11 S."}],"title":[{"subtitle":"a pooled analysis of individual patient data from eight prospectively randomized controlled trials","title":"Outcome after neoadjuvant chemotherapy in young breast cancer patients","title_sort":"Outcome after neoadjuvant chemotherapy in young breast cancer patients"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"25 June 2015"}],"relHost":[{"origin":[{"dateIssuedKey":"1981","publisherPlace":"Dordrecht [u.a.] ; Dordrecht [u.a.]","publisher":"Springer Science + Business Media B.V. ; Kluwer","dateIssuedDisp":"1981-"}],"title":[{"title":"Breast cancer research and treatment","title_sort":"Breast cancer research and treatment"}],"id":{"eki":["320433722"],"issn":["1573-7217"],"zdb":["2004077-5"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"320433722","disp":"Outcome after neoadjuvant chemotherapy in young breast cancer patients a pooled analysis of individual patient data from eight prospectively randomized controlled trialsBreast cancer research and treatment","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1981 -"],"note":["Gesehen am 02.12.05","Fortsetzung der Druck-Ausgabe"],"language":["eng"],"part":{"year":"2015","volume":"152","text":"152(2015), 2, Seite 377-387","issue":"2","extent":"11","pages":"377-387"}}]} 
SRT |a LOIBLSIBYLOUTCOMEAFT2520